MWA
IDXX icon

Medallion Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Medallion Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16
Closed -$8.99K – 1262
2026
Q1 		$8.99K Hold
16
– – ﹤0.01% 776
2025
Q4 		$10.8K Hold
16
– – ﹤0.01% 736
2025
Q3 		$10.2K Hold
16
– – ﹤0.01% 743
2025
Q2 		$8.58K Hold
16
– – ﹤0.01% 754
2025
Q1 		$6.72K Hold
16
– – ﹤0.01% 746
2024
Q4 		$6.72K Buy
+16
New +$7.02K ﹤0.01% 715

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Medallion Wealth Advisors's IDXX Position: Q2 2026 in Review

Medallion Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 16 shares — an estimated $8.99K sold.

Medallion Wealth Advisors first reported a position in IDXX in Q4 2024 and held it in 6 quarters. The position peaked at $10.8K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Medallion Wealth Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Medallion Wealth Advisors sold 16 Idexx Laboratories shares in Q2 2026, an estimated $8.99K.
  • Medallion Wealth Advisors first reported a position in Idexx Laboratories in Q4 2024 and held it in 6 quarters.
  • Medallion Wealth Advisors's Idexx Laboratories position peaked at $10.8K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.